Algorae Pharmaceuticals LimitedASX: 1AI

Peter Mac partners with Algorae on 3rd AI validation program

· Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Algorae Pharmaceuticals Limited has announced a partnership with the Victorian Centre for Functional Genomics at Peter MacCallum Cancer Centre for a third AI-driven drug synergy screening program. This initiative is supported by a Therapeutic Innovation Australia Pipeline Accelerator voucher awarded to the company.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/peter-mac-partners-with-algorae-on-3rd-ai-validation-program

Release

Algorae Pharmaceuticals Limited [ABN: 14 104 028 042] Level 23, Rialto South Tower, 525 Collins St, Melbourne VIC 3000 ASX ANNOUNCEMENT ASX: 1AI |16 October 2026 Algorae Pharmaceuticals Partners with Peter MacCallum Cancer Centre for Third AI-driven Drug Synergy Screening Program Highlights ...

Algorae Pharmaceuticals Limited on 6ix

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases